Biotechnology Biohaven Presents New Migraine Data at 64th Annual Scientific Meeting of the American Headache Society, including First of Its Kind Study for Nurtec® ODT (rimegepant), and Complete Phase 3 Data for Zavegepant Nasal Spray June 13, 2022
Biotechnology CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND® (mitapivat) to Treat Children With Rare Blood Disease June 13, 2022
Biotechnology ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AXSM June 12, 2022
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Blueprint Medicines Corporation – BPMC June 11, 2022
Biotechnology CRISPR Therapeutics Presents Positive Results from its Phase 1 COBALT(TM)-LYM Trial of CTX130(TM) in Relapsed or Refractory T Cell Malignancies at the 2022 European Hematology Association (EHA) Congress June 11, 2022
Health AbbVie Announces Late-Breaking Results from Phase 2 Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) at the European Hematology Association (EHA) Annual Congress June 11, 2022
Health ABBVIE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of AbbVie Inc. – ABBV June 10, 2022
Search
Health
